Centre notifies Uniform Code for Marketing Practices in Medical Devices 2024; mandates annual self-declarations on Code adherence and disclosure of expenses on medical education/conferences and free samples through UCPMP portal by Lexplosion Solution | Oct 9, 2024 | Central, OPS, PharmaceuticalsThe Department of Pharmaceuticals has notified the Uniform Code for Marketing Practices in Medical... Read More
Pharmaceutical companies mandated to disclose free sample and continuing medical education /conference related expenses on UCPMP portal within two months of financial year-end by Lexplosion Solution | Oct 9, 2024 | Central, OPS, PharmaceuticalsThe Department of Pharmaceuticals has directed pharmaceutical companies to submit a declaration... Read More
Health Ministry prohibits the manufacture, sale or distribution of 156 Fixed Dose Combinations by Lexplosion Solution | Oct 9, 2024 | Central, OPS, PharmaceuticalsThe Ministry of Health and Family Welfare (MoHFW) has implemented an immediate ban on 156... Read More
Health Ministry restricts the manufacture, sale or distribution of two Fixed Dose Combinations of Naproxen subject to certain conditions by Lexplosion Solution | Oct 9, 2024 | Central, OPS, PharmaceuticalsThe Ministry of Health and Family Welfare (“MoHFW”) has implemented restriction on the... Read More
Ministry of Health and Family Welfare prohibits the manufacture, sale, and distribution of S(+) Etodolac and Paracetamol Combination over safety concerns by Lexplosion Solution | Oct 9, 2024 | Central, OPS, PharmaceuticalsThe Health Ministry has prohibited the manufacture, sale, and distribution of the fixed-dose... Read More
CDSCO streamlines online application process for registration of cosmetics prior to import; restricts maximum number of products to 50 in single online application effective from 16th August, 2024 by Lexplosion Solution | Oct 9, 2024 | Central, OPS, PharmaceuticalsWith a view to streamline the online filing process for applications related to the mandatory... Read More